Department of Biochemistry

The Vanderbilt Ingram Cancer Center (Neil Brake/Vanderbilt)
September 10, 2025

Vanderbilt-Ingram Cancer Center names associate directors and new program leaders 

Shared resources at Vanderbilt-Ingram are designed to support and enhance cancer-relevant research and scientific interaction by providing access to cutting-edge technologies and services, as well as scientific expertise.

By Tom Wilemon
(Photo credit: iStock photo)
June 26, 2025

Three VUMC researchers receive Komen leadership grants

The grants support 25 cutting-edge projects at 17 institutions — marking a powerful commitment to improving outcomes for people living with breast cancer today and in the future.

By Tom Wilemon
New Academy for Excellence in Educations members include, from left, Gisella Carranza Leon, MD; Megan Dupuis, MD, PhD; Alvin Jeffery, PhD, RN, CCRN, FNP-BC; Mackenzie Mosera, MAT, MS, MPH, CGC; Anuj Patel, MD; Uchenna Anani, MD; Kristopher Kast, MD; Stacy Killen, MD, MSCI; and Kaitlin Ray, MD. (photo by Erin O. Smith)
May 21, 2025

Academy for Excellence in Education announces 2025 award winners and new members 

The mission of the academy is to enhance the educational environment in the Vanderbilt University School of Medicine and Vanderbilt University Medical Center.

By Doug Campbell
Pelayo Correa, MD
April 18, 2025

Pelayo Correa and John Kuriyan named fellows of the AACR Academy

Fellows of the AACR Academy constitute a global brain trust of leading experts in cancer science and medicine.

By Tom Wilemon
February 26, 2025

Vanderbilt University School of Medicine fifth in the nation in NIH research funding

The NIH is the world’s largest public funder of biomedical research. VUSM, which received $586 million in direct and indirect NIH grant support in FY24, has been among the top 10 recipients of NIH funding among U.S. medical schools for nine of the past 15 years.

By Bill Snyder
(photo by Erin O. Smith)
September 30, 2024

Ramakrishnan’s Discovery Lecture

Nobel laureate Venki Ramakrishnan, PhD, center, author of Why We Die: The New Science of Aging and the Quest for Immortality, delivered the Sept. 26 Discovery Lecture.

By Bill Snyder
July 15, 2024

Katrin Karbstein appointed co-leader of Vanderbilt’s Cancer Cell Biology Research Program

There, she will develop and implement program aims, participate in strategic decision-making in the Cancer Center, direct pilot project funding, facilitate interactions among Cancer Center members, and assist in the recruiting activities for the 42-member program with over $11.7 million in annual peer-reviewed funding.
By Marissa Shapiro
April 5, 2024

Pietenpol to receive ASCO’s highest honor

Jennifer Pietenpol, PhD, will be recognized at the annual meeting of the American Society of Clinical Oncology (ASCO) with one of its highest honors.
By Tom Wilemon
December 15, 2023

Clinical trial shows efficacy for atezolizumab combined with carboplatin

By Tom Wilemon
October 30, 2023

Crowe, Osheroff honored by AAMC

Vanderbilt's James E. Crowe, Jr, MD, and Neil Osheroff, PhD, are among 12 individuals honored by the Association of American Medical Colleges during its 2023 Awards Recognition Event.
By Bill Snyder
October 27, 2023

Study discovers role for gut bacteria in host-pathogen competition for nutrients

Vanderbilt research shows that commensal gut microbes impact the host-pathogen competition for iron and has implications for therapeutic strategies aimed at preventing pathogens from acquiring essential nutrients.
By Leigh MacMillan
September 15, 2023

Four named Master Innovators at Vanderbilt

Richard Caprioli, C. David Weaver, Susan Eagle, and Franz Baudenbacher as Master Innovators at Vanderbilt.
By Sarah Sommer
September 1, 2023

Foundation funds research to block drug resistance in cancer treatment

The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation has funded an ambitious initiative to overcome one of the most perplexing and frustrating mysteries of cancer treatment — how to prevent drug resistance.
By Tom Wilemon
1 2 3 … 16